Article
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
Gene - 10 Feb 2014
Duro Giovanni, Musumeci M Beatrice, Colomba Paolo, Zizzo Carmela, Albeggiani Giuseppe, Mastromarino Vittoria, Volpe Massimo, Autore Camillo
Abstract excerpt
Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of α-galactosidase A (α-gal A), a lysosomal hydrolase. This inactivation is responsible for the accumulation of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. Fabry is considered a rare disease, with an incidence of 1:40,000; however, there are good reasons to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
